Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacological profile of risperidone

L Ereshefsky1, S Lacombe

  • 1University of Texas Health Sciences Center, Austin.

Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|September 1, 1993
PubMed
Summary

Risperidone, an atypical antipsychotic, effectively blocks serotonin-5-HT2 and dopamine-D2 receptors. Its pharmacokinetics are dose-linear, with a metabolite contributing to its efficacy in treating schizophrenia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Near-complete genome sequences of a rice necrosis mosaic virus isolate infecting rice in Argentina.

Microbiology resource announcements·2025
Same author

Mapping of validated apathy scales onto the apathy diagnostic criteria for neurocognitive disorders.

International psychogeriatrics·2025
Same author

Rice yellow mottle virus is a suitable amplicon vector for an efficient production of an anti-leishmianiasis vaccine in Nicotiana benthamiana leaves.

BMC biotechnology·2024
Same author

Validation of a suite of ERP and QEEG biomarkers in a pre-competitive, industry-led study in subjects with schizophrenia and healthy volunteers.

Schizophrenia research·2023
Same author

A Framework for Developing Pharmacotherapy for Agitation in Alzheimer's Disease: Recommendations of the ISCTM* Working Group.

The journal of prevention of Alzheimer's disease·2020
Same author

Is current age related macular degeneration self-monitoring a good tool for detecting exudative recurrence?

Journal francais d'ophtalmologie·2019

Area of Science:

  • Pharmacology
  • Neuroscience
  • Psychiatry

Background:

  • Schizophrenia pathophysiology involves serotonin and dopamine neurotransmission.
  • Atypical antipsychotics, like risperidone, differ from typical antipsychotics in their receptor binding profiles.
  • Risperidone exhibits potent serotonin-5-HT2 and dopamine-D2 receptor antagonism.

Purpose of the Study:

  • To present the pharmacodynamics and pharmacokinetics of risperidone.
  • To discuss atypical versus typical antipsychotic pharmacology in schizophrenia.
  • To explore the role of serotonin and excitatory amino acid neurotransmission in schizophrenia.

Main Methods:

  • Review of risperidone's receptor binding profile.
  • Analysis of risperidone's pharmacokinetic and pharmacodynamic properties.
  • Discussion of schizophrenia models incorporating neurotransmitter roles.

Main Results:

  • Risperidone demonstrates dose-linear pharmacokinetics in humans within the therapeutic range.
  • Steady-state plasma concentrations of risperidone are achieved within 24 hours.
  • Risperidone is metabolized to 9-OH-risperidone, an active metabolite with a similar pharmacological profile.

Conclusions:

  • Risperidone's pharmacological profile contributes to its clinical efficacy.
  • The active metabolite 9-OH-risperidone enhances risperidone's therapeutic effect.
  • Understanding risperidone's pharmacokinetics is crucial for its effective use in schizophrenia treatment.

Related Experiment Videos